Industrias Peñoles, S.A.B. de C.V. - IPOAF

IPOAF Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
IPOAF	4.2	4.2	-0.4	19.9	-7.4	8.7	18.6	25.1	-28.9	237.1
S&P 500	-1.3	-1.9	0.1	5.7	10.7	29.1	24.8	88.0	186.1	33142.5

Compare IPOAF with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	IPOAF
name	Industrias Peñoles, S.A.B. de C.V.
price	15
changes percentage	4.17
change	0.60
day low	14.40
day high	15
year high	20.30
year low	11.43
market cap	5962140000
price avg 50	14.10
price avg 200	14.07
exchange	PNK
volume	4100
avg volume	44496
open	14.40
previous close	14.40
eps	0.21
pe	71.43
earnings announcement	2025-03-11T12:00:00.000+0000
shares outstanding	397476000
timestamp	2024-11-15 15:51:36

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 37.7%

Overall Quarterly Financial Health: 87.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	6178289203	5523358000	11.86
gross profit	552576659	1032454000	-46.48
gross profit ratio	0.09	0.19	-52.15
research and development expenses	0	0	NaN
operating expenses	690891000	619782000	11.47
interest income	43556000	35265000	23.51
interest expense	194706000	159583000	22.01
ebitda	792440057	1179874763	-32.84
ebitdaratio	0.13	0.19	-34.15
operating income	95447000	379488000	-74.85
operating income ratio	0.02	0.07	-77.51
net income	147090000	183363000	-19.78
net income ratio	0.02	0.03	-28.29
eps	0.37	0.48	-22.92

Overall Score of Annual Income Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 6,178 million in 2023 from 5,523 million in 2022 representing a change of 11.86%. This indicates a sales growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 792 million in 2023 from 1,180 million in 2022 representing a change of -32.84%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 95 million in 2023 from 379 million in 2022 representing a change of -74.85%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 553 million in 2023 from 1,032 million in 2022 representing a change of -46.48%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 691 million in 2023 from 620 million in 2022 representing a change of 11.47%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 147 million in 2023 from 183 million in 2022 representing a change of -19.78%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.37 in 2023 from 0.37 in 2022 representing a change of -22.92%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	1732223000	1533224720	12.98
gross profit	523420000	329234378	58.98
gross profit ratio	0.3	0.21	40.72
research and development expenses	0	0	NaN
operating expenses	176258000	121709643	44.82
interest income	17905995	15279000	17.19
interest expense	38916000	39090000	-0.45
ebitda	597250000	396974271	50.45
ebitdaratio	0.34	0.26	33.17
operating income	366714000	207524733	76.71
operating income ratio	0.21	0.14	56.41
net income	40065000	-21801788	283.77
net income ratio	0.02	-0.01	262.66
eps	0.1	-0.05	282.15

Overall Score of Quarterly Income Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1,732 million in 2024Q3 from 1,533 million in 2024Q2 representing a change of 12.98%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 523 million in 2024Q3 from 329 million in 2024Q2 representing a change of 58.98%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 597 million in 2024Q3 from 397 million in 2024Q2 representing a change of 50.45%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 367 million in 2024Q3 from 208 million in 2024Q2 representing a change of 76.71%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 40 million in 2024Q3 from -22 million in 2024Q2 representing a change of 283.77%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.1 in 2024Q3 from 0.1 in 2024Q2 representing a change of 282.15%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 176 million in 2024Q3 from 122 million in 2024Q2 representing a change of 44.82%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	9949504719	10042527000	-0.93
total liabilities	4473468000	4754251000	-5.91
total equity	5489373524	5288276000	3.80
cash and cash equivalents	1040222000	1468918000	-29.18
short term investments	43298920	-40451162	207.04
long term investments	239138920	279755162	-14.52
total current assets	3627123000	4122386000	-12.01
total non current assets	6354493619	5920141000	7.34
total current liabilities	1129055000	1380759000	-18.23
total non current liabilities	3344413000	3373492000	-0.86
common stock	403736000	401399000	0.58
retained earnings	3834771000	3635377000	5.48
total debt	2891956000	3016026000	-4.11

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 9,950 million in 2023 from 10,043 million in 2022 representing a change of -0.93%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,040 million in 2023 from 1,469 million in 2022 representing a change of -29.18%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 3,627 million in 2023 from 4,122 million in 2022 representing a change of -12.01%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 4,473 million in 2023 from 4,754 million in 2022 representing a change of -5.91%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 5,489 million in 2023 from 5,288 million in 2022 representing a change of 3.8%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 43 million in 2023 from -40 million in 2022 representing a change of 207.04%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 1,129 million in 2023 from 1,381 million in 2022 representing a change of -18.23%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 404 in 2023 from 401 in 2022 representing a change of 0.58%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 3,835 million in 2023 from 3,635 million in 2022 representing a change of 5.48%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2,892 million in 2023 from 3,016 million in 2022 representing a change of -4.11%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	10137179000	10092756716	0.44
total liabilities	4561974000	4605010047	-0.93
total equity	5553597997	5487746668	1.20
cash and cash equivalents	1501941000	1242028556	20.93
short term investments	39056000	0	NaN
long term investments	252879553	219727356	15.09
total current assets	4218745000	3983255552	5.91
total non current assets	5918434000	6109501164	-3.13
total current liabilities	1093284000	1221934527	-10.53
total non current liabilities	3468690000	3383075520	2.53
common stock	401399000	400164882	0.31
retained earnings	3812647000	3760983045	1.37
total debt	3106488000	2951346981	5.26

Overall Score of Quarterly Balance Sheet

0.9 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 10,137 million in 2024Q3 from 10,093 million in 2024Q2 representing a change of 0.44%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 4,562 million in 2024Q3 from 4,605 million in 2024Q2 representing a change of -0.93%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 5,554 million in 2024Q3 from 5,488 million in 2024Q2 representing a change of 1.2%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,502 million in 2024Q3 from 1,242 million in 2024Q2 representing a change of 20.93%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 39 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 4,219 million in 2024Q3 from 3,983 million in 2024Q2 representing a change of 5.91%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 1,093 million in 2024Q3 from 1,222 million in 2024Q2 representing a change of -10.53%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 401 in 2024Q3 from 400 in 2024Q2 representing a change of 0.31%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 3,813 million in 2024Q3 from 3,761 million in 2024Q2 representing a change of 1.37%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 3,106 million in 2024Q3 from 2,951 million in 2024Q2 representing a change of 5.26%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-430491810	-348176000	-23.64
operating cash flow	377435967	663005000	-43.07
free cash flow	-244799645	-89580000	-173.27
capital expenditure	-599866000	-752585000	20.29
depreciation and amortization	786693287	690579000	13.92
deferred income tax	-527832752	-387802499	-36.11
stock based compensation	0	0	NaN
accounts payables	103672685	-55356877	287.28
inventory	93564136	-189226000	149.45
acquisitions net	15269361	-12016000	227.08
investments in property plant and equipment	-622235612	-752585000	17.32
net cash used for investing activites	-580115613	-692526000	16.23
debt repayment	-216127421	-59134000	-265.49
common stock issued	10097059	0	NaN
common stock repurchased	-23251325	0	NaN
dividends paid	-8000	-2063.44	-287.70
net cash used provided by financing activities	-252718949	-318540000	20.66
cash at end of period	1037120773	1468918000	-29.40
accounts receivables	-90238488	-19426235	-364.52
cash at beginning of period	1467612583	1817094000	-19.23

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	497110000	260530689	90.81
free cash flow	398896000	167371266	138.33
capital expenditure	-98214000	-93159423	-5.43
depreciation and amortization	220374000	189449537	16.32
deferred income tax	0	94951459	-100.00
stock based compensation	0	0	NaN
accounts receivables	-4729000	22545330	-120.98
accounts payables	1010578	20135192	-94.98
inventory	-23509000	-164163969	85.68
acquisitions net	820423	1588355	-48.35
investments in property plant and equipment	-93463957	-93159423	-0.33
net cash used for investing activites	-82663000	-90435229	8.59
debt repayment	-55291783	29214000	-289.26
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-25271423	0	NaN
net cash used provided by financing activities	-152870000	-19743330	-674.29
net change in cash	256082000	148899361	71.98
cash at end of period	1501941000	1242028556	20.93
cash at beginning of period	1245859000	1093129195	13.97

Overall Score of Quarterly Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 256 million in 2024Q3 from 149 million in 2024Q2 representing a change of 71.98%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 497 million in 2024Q3 from 261 million in 2024Q2 representing a change of 90.81%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 399 million in 2024Q3 from 167 million in 2024Q2 representing a change of 138.33%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -98 million in 2024Q3 from -93 million in 2024Q2 representing a change of -5.43%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2024Q3 from 20 million in 2024Q2 representing a change of -94.98%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -5 million in 2024Q3 from 23 million in 2024Q2 representing a change of -120.98%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Dividends Paid: Dividends Paid decreased to -25 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	15.54	13.9	11.86
net income per share	0.37	0.46	-19.78
operating cash flow per share	0.95	1.67	-43.07
free cash flow per share	-0.62	-0.23	-173.27
cash per share	2.73	3.59	-24.15
book value per share	13.78	13.3	3.55
tangible book value per share	13.76	14.01	-1.75
shareholders equity per share	10.56	10.25	3.02
interest debt per share	7.67	7.72	-0.61
market cap	5962140000	5365926000	11.11
enterprise value	7813874000	6913034000	13.03
pe ratio	40.53	29.26	38.51
price to sales ratio	0.97	0.97	-0.67
pocfratio	15.8	8.09	95.18
pfcf ratio	-24.36	-59.9	59.34
pb ratio	1.42	1.32	7.85
ptb ratio	1.42	1.32	7.85
ev to sales	1.26	1.25	1.05
enterprise value over ebitda	9.86	5.86	68.29
ev to operating cash flow	20.7	10.43	98.55
ev to free cash flow	-31.92	-77.17	58.64
earnings yield	0.02	0.03	-27.80
free cash flow yield	-0.04	-0.02	-145.95
debt to equity	0.68	0.71	-4.73
debt to assets	0.29	0.29	-0.93
net debt to ebitda	2.34	1.31	78.21
current ratio	3.21	2.99	7.60
interest coverage	0.49	2.38	-79.39
income quality	2.46	2.04	20.64
dividend yield	0.0	0.0	248.93
payout ratio	0.0	0.0	383.31
sales general and administrative to revenue	0.03	0.03	6.22
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.0	-0.03	101.89
capex to operating cash flow	1.59	1.14	40.01
capex to revenue	0.1	0.14	-28.74
capex to depreciation	0.76	1.09	-30.03
stock based compensation to revenue	0	0	NaN
graham number	9.38	10.31	-9.09
roic	-0.07	0.08	-186.92
return on tangible assets	0.01	0.02	-16.73
graham net net	-5.97	-5.49	-8.57
working capital	2498068000	2741627000	-8.88
tangible asset value	5470806719	5568031162	-1.75
net current asset value	-846345000	-631865000	-33.94
invested capital	7242928427	7270950838	-0.39
average receivables	214265000	245413500	-12.69
average payables	306566500	384936500	-20.36
average inventory	1839547000	1799353000	2.23
days sales outstanding	9.43	17.77	-46.93
days payables outstanding	13.92	32.39	-57.02
days of inventory on hand	116.68	152.85	-23.66
receivables turnover	38.7	20.54	88.41
payables turnover	26.22	11.27	132.65
inventory turnover	3.13	2.39	30.99
roe	0.04	0.05	-22.14
capex per share	1.51	1.89	-20.29

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2023-12-31 from 0.05 on 2022-12-31, representing a change of -22.14%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 3.21 on 2023-12-31 from 2.99 on 2022-12-31, representing a change of 7.60%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 40.53 on 2023-12-31 from 29.26 on 2022-12-31, representing a change of 38.51%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.68 on 2023-12-31 from 0.71 on 2022-12-31, representing a change of -4.73%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
IPOAF
calendar year	2024	2024	NaN
revenue per share	4.36	3.86	12.98
net income per share	0.1	-0.05	283.77
operating cash flow per share	1.25	0.66	90.81
free cash flow per share	1.0	0.42	138.33
cash per share	3.88	3.12	24.07
book value per share	14.03	13.81	1.59
tangible book value per share	14.01	13.79	1.59
shareholders equity per share	10.48	10.42	0.55
interest debt per share	7.66	7.39	3.67
market cap	5187061800	5306304600	-2.25
enterprise value	6791608800	7015623025	-3.19
pe ratio	32.37	-60.85	153.19
price to sales ratio	2.99	3.46	-13.48
pocfratio	10.43	20.37	-48.77
pfcf ratio	13.0	31.7	-58.98
pb ratio	1.24	1.28	-2.78
ptb ratio	1.24	1.28	-2.78
ev to sales	3.92	4.58	-14.31
enterprise value over ebitda	11.37	17.67	-35.66
ev to operating cash flow	13.66	26.93	-49.26
ev to free cash flow	17.03	41.92	-59.38
earnings yield	0.01	-0.0	287.99
free cash flow yield	0.08	0.03	143.81
debt to equity	0.72	0.7	3.15
debt to assets	0.3	0.29	3.27
net debt to ebitda	2.69	4.31	-37.61
current ratio	3.86	3.26	18.38
interest coverage	9.42	5.31	77.50
income quality	5.72	-11.95	147.89
dividend yield	0.0	0	NaN
payout ratio	0.63	0	NaN
sales general and administrative to revenue	0.02	0.03	-20.43
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.0	0.0	7.63
capex to operating cash flow	0.2	0.36	-44.75
capex to revenue	0.06	0.06	-6.69
capex to depreciation	0.45	0.49	-9.37
stock based compensation to revenue	0	0	NaN
graham number	4.88	3.59	35.93
roic	0.01	0.0	236.56
return on tangible assets	0.0	-0.0	282.97
graham net net	-4.0	-4.69	14.78
working capital	3125461000	2761321025	13.19
tangible asset value	5570070000	5482996669	1.59
net current asset value	-343229000	-621754495	44.80
invested capital	7529751000	7276903518	3.47
average receivables	611777450.5	659887767	-7.29
average payables	330901500	327003500	1.19
average inventory	2011474983.5	1920271988	4.75
days sales outstanding	29.26	38.77	-24.54
days payables outstanding	25.0	24.37	2.60
days of inventory on hand	150.25	149.87	0.26
receivables turnover	3.08	2.32	32.52
payables turnover	3.6	3.69	-2.53
inventory turnover	0.6	0.6	-0.26
roe	0.01	-0.01	282.76
capex per share	0.25	0.23	5.43

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2024-09-30 Q3 from -0.01 on 2024-06-30 Q2, representing a change of 282.76%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 3.86 on 2024-09-30 Q3 from 3.26 on 2024-06-30 Q2, representing a change of 18.38%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 32.37 on 2024-09-30 Q3 from -60.85 on 2024-06-30 Q2, representing a change of 153.19%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.72 on 2024-09-30 Q3 from 0.70 on 2024-06-30 Q2, representing a change of 3.15%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is -0.05 which is lower than current price 15, indicates the company may be overvalued.